Skip to main content
Top
Published in: Annals of Nuclear Medicine 4/2010

01-05-2010 | Original Article

What can be identified by three-phase bone scintigraphy in patients with chronic osteomyelitis of the mandible?

Authors: Nobuyoshi Fukumitsu, Kiyoto Ujigawa, Yutaka Mori, Kenkichi Auchi, Kazuo Miida, Satoshi Tatsuno, Morio Tonogi, Yutaka Aoyagi, Gen-yuki Yamane

Published in: Annals of Nuclear Medicine | Issue 4/2010

Login to get access

Abstract

Objective

Three-phase bone scintigraphy has been used for the diagnosis of osteomyelitis in some regions of the body. However, its utility in patients with chronic osteomyelitis of the mandible (COM) has been reported only occasionally and the significance has not been fully examined. The aim of this study was to investigate what can be identified from each phase of the three-phase bone scintigraphy in patients with COM.

Methods

Three-phase bone scintigraphy using 99mTc-labeled phosphonates was performed [96 s (phase 1), 5 min (phase 2) and 3 h (phase 3)] in 15 patients with COM. An increase in accumulation was regarded as a positive result in visual analysis. We investigated the positive ratio of each phase, including in the classification of the disease type, serum white blood cell count, C-reactive protein value and morbidity period. We also calculated the uptake ratio relative to the contralateral side using mean and maximum counts of the region of interest in semiquantitative analysis and investigated the correlation between the uptake ratios of each phase.

Results

The positive ratio of phases 2 and 3 was 100% and higher than that of phase 1 (33.3%, p = 0.0001). Almost all patients with a positive result in phase 1 had the osteolytic type (5/6). The extent of increased uptake on phase 3 images was similar to that of phase 2 images. The uptake ratio of phase 2 correlated with that of phase 3 (mean: r = 0.88, p < 0.0001, max: r = 0.78, p = 0.0006), but was not as high as that of phase 3.

Conclusions

The phase 1 results reflect hyperemia and have a strong potential to diagnose the disease type. Phase 3 alone is sufficient to diagnose the disease and the extent of lesion in patients with highly suspected COM.
Literature
1.
go back to reference Guhlmann A, Brecht-Krauss D, Suger G, Glatting G, Kotzerke J, Kinzl L, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology. 1998;206:749–54.PubMed Guhlmann A, Brecht-Krauss D, Suger G, Glatting G, Kotzerke J, Kinzl L, et al. Chronic osteomyelitis: detection with FDG PET and correlation with histopathologic findings. Radiology. 1998;206:749–54.PubMed
2.
go back to reference Schuknecht B, Valavanis A. Osteomyelitis of the mandible. Neuroimaging Clin N Am. 2003;13:605–18.CrossRefPubMed Schuknecht B, Valavanis A. Osteomyelitis of the mandible. Neuroimaging Clin N Am. 2003;13:605–18.CrossRefPubMed
3.
go back to reference Schauwecker DS. The role of nuclear medicine in osteomyelitis. In: Collier Jr BD, Fogelman I, Rosenthall R, editors. Skeletal nuclear medicine. St. Louis: Mosby; 1996. p. 183–202. Schauwecker DS. The role of nuclear medicine in osteomyelitis. In: Collier Jr BD, Fogelman I, Rosenthall R, editors. Skeletal nuclear medicine. St. Louis: Mosby; 1996. p. 183–202.
4.
go back to reference Davenport MS, Brown RK, Frey KA. Utility of delayed whole-body bone scintigraphy after directed three-phase scintigraphy. AJR. 2009;193:338–42.CrossRefPubMed Davenport MS, Brown RK, Frey KA. Utility of delayed whole-body bone scintigraphy after directed three-phase scintigraphy. AJR. 2009;193:338–42.CrossRefPubMed
5.
go back to reference Yang DC, Ratani RS, Mittal PK, Chua RS, Pate SM. Radionuclide three-phase whole-body bone imaging. Clin Nucl Med. 2002;27:419–26.CrossRefPubMed Yang DC, Ratani RS, Mittal PK, Chua RS, Pate SM. Radionuclide three-phase whole-body bone imaging. Clin Nucl Med. 2002;27:419–26.CrossRefPubMed
6.
go back to reference El-Maghraby TA, Moustafa HM, Pauwels EK. Nuclear medicine methods for evaluation of skeletal infection among other diagnostic modalities. Q J Nucl Med Mol Imaging. 2006;50:167–92.PubMed El-Maghraby TA, Moustafa HM, Pauwels EK. Nuclear medicine methods for evaluation of skeletal infection among other diagnostic modalities. Q J Nucl Med Mol Imaging. 2006;50:167–92.PubMed
7.
go back to reference Maurer AH, Chen DC, Camargo EE, Wong DF, Wagner HN Jr, Alderson PO. Utility of three-phase skeletal scintigraphy in suspected osteomyelitis: concise communication. J Nucl Med. 1981;22:941–9.PubMed Maurer AH, Chen DC, Camargo EE, Wong DF, Wagner HN Jr, Alderson PO. Utility of three-phase skeletal scintigraphy in suspected osteomyelitis: concise communication. J Nucl Med. 1981;22:941–9.PubMed
8.
go back to reference Buyukdereli G, Guney IB, Ozerdem G, Kesiktas E. Evaluation of vascularized graft reconstruction of the mandible with Tc-99m MDP bone scintigraphy. Ann Nucl Med. 2006;20:89–93.CrossRefPubMed Buyukdereli G, Guney IB, Ozerdem G, Kesiktas E. Evaluation of vascularized graft reconstruction of the mandible with Tc-99m MDP bone scintigraphy. Ann Nucl Med. 2006;20:89–93.CrossRefPubMed
9.
go back to reference Dore F, Filippi L, Biasotto M, Chiandussi S, Cavalli F, Di Lenarda R. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw. J Nucl Med. 2009;50:30–5.CrossRefPubMed Dore F, Filippi L, Biasotto M, Chiandussi S, Cavalli F, Di Lenarda R. Bone scintigraphy and SPECT/CT of bisphosphonate-induced osteonecrosis of the jaw. J Nucl Med. 2009;50:30–5.CrossRefPubMed
10.
go back to reference Hakim SG, Bruecker CW, HCh Jacobsen, Hermes D, Lauer I, Eckerle S, et al. The value of FDG-PET and bone scintigraphy with SPECT in the primary diagnosis and follow-up of patients with chronic osteomyelitis of the mandible. Int J Oral Maxillofac Surg. 2006;35:809–16.CrossRefPubMed Hakim SG, Bruecker CW, HCh Jacobsen, Hermes D, Lauer I, Eckerle S, et al. The value of FDG-PET and bone scintigraphy with SPECT in the primary diagnosis and follow-up of patients with chronic osteomyelitis of the mandible. Int J Oral Maxillofac Surg. 2006;35:809–16.CrossRefPubMed
11.
go back to reference Rohlin M. Diagnostic value of bone scintigraphy in osteomyelitis of the mandible. Oral Surg Oral Med Oral Pathol. 1993;75:650–7.CrossRefPubMed Rohlin M. Diagnostic value of bone scintigraphy in osteomyelitis of the mandible. Oral Surg Oral Med Oral Pathol. 1993;75:650–7.CrossRefPubMed
12.
go back to reference Tsuchimochi M, Higashino N, Okano A, Kato J. Study of combined technetium 99m methylene diphosphonate and gallium 67 citrate scintigraphy in diffuse sclerosing osteomyelitis of the mandible: case reports. J Oral Maxillofac Surg. 1991;49:887–97.CrossRefPubMed Tsuchimochi M, Higashino N, Okano A, Kato J. Study of combined technetium 99m methylene diphosphonate and gallium 67 citrate scintigraphy in diffuse sclerosing osteomyelitis of the mandible: case reports. J Oral Maxillofac Surg. 1991;49:887–97.CrossRefPubMed
13.
go back to reference Jacobsson S, Hollender L, Lindberg S, Larsson A. Chronic sclerosing osteomyelitis of the mandible. Scintigraphic and radiographic findings. Oral Surg Oral Med Oral Pathol. 1978;45:167–74.CrossRefPubMed Jacobsson S, Hollender L, Lindberg S, Larsson A. Chronic sclerosing osteomyelitis of the mandible. Scintigraphic and radiographic findings. Oral Surg Oral Med Oral Pathol. 1978;45:167–74.CrossRefPubMed
14.
go back to reference Gilday DL, Paul DJ, Paterson J. Diagnosis of osteomyelitis in children by combined blood pool and bone imaging. Radiology. 1975;117:331–5.PubMed Gilday DL, Paul DJ, Paterson J. Diagnosis of osteomyelitis in children by combined blood pool and bone imaging. Radiology. 1975;117:331–5.PubMed
15.
go back to reference Yoshii T, Nishimura H, Yoshikawa T, Furudoi S, Yoshioka A, Takenono I, et al. Therapeutic possibilities of long-term roxithromycin treatment for chronic diffuse sclerosing osteomyelitis of the mandible. J Antimicrob Chemother. 2001;47:631–7.CrossRefPubMed Yoshii T, Nishimura H, Yoshikawa T, Furudoi S, Yoshioka A, Takenono I, et al. Therapeutic possibilities of long-term roxithromycin treatment for chronic diffuse sclerosing osteomyelitis of the mandible. J Antimicrob Chemother. 2001;47:631–7.CrossRefPubMed
16.
go back to reference Kumta SM, Huang L, Cheng YY, Chow LT, Lee KM, Zheng MH. Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions. Life Sci. 2003;73:1427–36.CrossRefPubMed Kumta SM, Huang L, Cheng YY, Chow LT, Lee KM, Zheng MH. Expression of VEGF and MMP-9 in giant cell tumor of bone and other osteolytic lesions. Life Sci. 2003;73:1427–36.CrossRefPubMed
17.
go back to reference Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med. 1999;190:293–8.CrossRefPubMed Niida S, Kaku M, Amano H, Yoshida H, Kataoka H, Nishikawa S, et al. Vascular endothelial growth factor can substitute for macrophage colony-stimulating factor in the support of osteoclastic bone resorption. J Exp Med. 1999;190:293–8.CrossRefPubMed
18.
go back to reference Lee K, Kaneda T, Mori S, Minami M, Motohashi J, Yamashiro M. Magnetic resonance imaging of normal and osteomyelitis in the mandible: assessment of short inversion time inversion recovery sequence. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:499–507.CrossRefPubMed Lee K, Kaneda T, Mori S, Minami M, Motohashi J, Yamashiro M. Magnetic resonance imaging of normal and osteomyelitis in the mandible: assessment of short inversion time inversion recovery sequence. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:499–507.CrossRefPubMed
Metadata
Title
What can be identified by three-phase bone scintigraphy in patients with chronic osteomyelitis of the mandible?
Authors
Nobuyoshi Fukumitsu
Kiyoto Ujigawa
Yutaka Mori
Kenkichi Auchi
Kazuo Miida
Satoshi Tatsuno
Morio Tonogi
Yutaka Aoyagi
Gen-yuki Yamane
Publication date
01-05-2010
Publisher
Springer Japan
Published in
Annals of Nuclear Medicine / Issue 4/2010
Print ISSN: 0914-7187
Electronic ISSN: 1864-6433
DOI
https://doi.org/10.1007/s12149-010-0362-1

Other articles of this Issue 4/2010

Annals of Nuclear Medicine 4/2010 Go to the issue